This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: CXO FIO MPC NOV SFM

Haemonetics (HAE) estimates, price target were boosted at Benchmark. Shares are now seen reaching $49. New analyst also raised estimates, as the company has premium pricing power, Benchmark said. Buy rating.

[Read: <a target="blank" data-add-tracking="true" href=""><em>What Three Financial Experts Would Do With Your Last $1,000</em></a>]

Las Vegas Sands (LVS) price target was raised at J.P. Morgan to $72. Multiple positive near-term and longer-term catalysts, J.P. Morgan said. Overweight rating.

Merck (MRK) estimates were increased at BMO Capital through 2014. Company has a solid pipeline, and Januvia can continue to growth, BMO Capital said. Market Perform rating and $50 price target.

M&T Bank (MTB) numbers were cut at BMO Capital. Shares are now seen reaching $121. Estimates were also reduced, given the company's new guidance, BMO Capital said. Market Perform rating.

Noble (NE) estimates were raised at UBS. Reflect five new jackup contracts, said UBS. Price target is $41.

Oasis Petroleum (OAS) numbers were increased at Sterne Agee. Estimates were boosted through 2015. Recent acquisition should add to earnings, Sterne Agee said. Buy rating and new $54 price target.

Palo Alto (PANW) numbers were raised at BMO Capital. Shares are now seen reaching $50. Estimates were also increased, given better license and billings growth, BMO Capital said. Market Perform rating.

Raytheon (RTN) estimates, price target were increased at Jefferies. Estimates were raised through 2014. Company is gaining market share and can continue to grow overseas, Jefferies said. Buy rating and new $87 price target.

Zoetis (ZTS) was added to the US 1 List at Bank of America/Merrill Lynch. Profit margin acceleration story is underappreciated by the market, BofA/Merrill said. $36 price target.

>To submit a news tip, email:

Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
FIO $0.00 0.00%
CXO $87.27 0.00%
MPC $32.30 0.00%
NOV $28.47 0.00%
SFM $22.96 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs